Skip to main content
CBT
NYSE Industrial Applications And Services

Retiring CEO Sean Keohane Files to Sell $7.94M in Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Neutral
Importance info
7
Price
$87.38
Mkt Cap
$4.512B
52W Low
$58.33
52W High
$94.53
52W Position info
50% above low
Off High info
7.6% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CBT sits 50% above its 52-week low of $58.33.

Summary

Outgoing CEO Sean Keohane filed to sell $7.94 million in Cabot shares, acquired via option exercise, as part of his planned retirement transition.


Key Events · Ownership and Investor Activity · CBT

  • CEO Files to Sell $7.94M in Shares

    Sean Keohane, CEO and Director, filed a Form 144 to sell 91,923 shares (~$7.94M) acquired via option exercise, with sale date August 7, 2026.

  • Sale Represents 0.18% of Outstanding Shares

    The proposed sale equals 0.18% of the 51.6 million shares outstanding, a modest but notable transaction for a retiring CEO.

  • Follows Strong Q3 Results and FY26 Guidance

    The filing comes days after Cabot reported fiscal Q3 adjusted EPS of $1.67, beating estimates, and initiated FY26 adjusted EPS guidance of $6.15–$6.45.

  • CEO Retirement Announced July 30

    Keohane's retirement effective September 30, 2026, was disclosed in an 8-K on July 30; CFO Erica McLaughlin will succeed him.


Analysis · CBT · Industrial Applications And Services

Outgoing CEO Sean Keohane, who is set to retire on September 30, 2026, has filed a Form 144 to sell 91,923 shares worth approximately $7.94 million. The shares were acquired through an option exercise on the same day. While the sale represents a modest 0.18% of outstanding shares, it comes just days after the company reported strong Q3 results and initiated FY26 guidance, and amid a planned CEO transition. The timing and size of the sale by a retiring CEO warrant attention, though it may reflect personal financial planning rather than a negative signal on the company's prospects.

At the time of this filing, CBT was trading at $87.38 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $4.5B. The 52-week trading range was $58.33 to $94.53. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CBT - Latest Insights

CBT
Aug 04, 2026, 2:58 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $81.20
Real-time Price: $87.50 info
Change: +$6.30 (+8%) info
Market Cap: $4.518B info
CBT
Aug 03, 2026, 4:52 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $89.58
Real-time Price: $87.50 info
Change: -$2.08 (-2%) info
Market Cap: $4.518B info
CBT
Aug 03, 2026, 4:39 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $79.83
Real-time Price: $87.50 info
Change: +$7.67 (+10%) info
Market Cap: $4.518B info
CBT
Aug 03, 2026, 4:36 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $89.58
Real-time Price: $87.50 info
Change: -$2.08 (-2%) info
Market Cap: $4.518B info
CBT
Jul 30, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $91.43
Real-time Price: $87.50 info
Change: -$3.93 (-4%) info
Market Cap: $4.518B info